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Abstract
Smoking is responsible for the majority of periodontitis cases in the US and smokers are more susceptible than non-smokers
to infection by the periodontal pathogen Porphyromonas gingivalis. P. gingivalis colonization of the oral cavity is dependent
upon its interaction with other plaque bacteria, including Streptococcus gordonii. Microarray analysis suggested that
exposure of P. gingivalis to cigarette smoke extract (CSE) increased the expression of the major fimbrial antigen (FimA), but
not the minor fimbrial antigen (Mfa1). Therefore, we hypothesized that CSE promotes P. gingivalis-S. gordonii biofilm
formation in a FimA-dependent manner. FimA total protein and cell surface expression were increased upon exposure to
CSE whereas Mfa1 was unaffected. CSE exposure did not induce P. gingivalis auto-aggregation but did promote dual species
biofilm formation, monitored by microcolony numbers and depth (both, p,0.05). Interestingly, P. gingivalis biofilms grown
in the presence of CSE exhibited a lower pro-inflammatory capacity (TNF-a, IL-6) than control biofilms (both, p,0.01). CSE-
exposed P. gingivalis bound more strongly to immobilized rGAPDH, the cognate FimA ligand on S. gordonii, than control
biofilms (p,0.001) and did so in a dose-dependent manner. Nevertheless, a peptide representing the Mfa1 binding site on
S. gordonii, SspB, completely inhibited dual species biofilm formation. Thus, CSE likely augments P. gingivalis biofilm
formation by increasing FimA avidity which, in turn, supports initial interspecies interactions and promotes subsequent high
affinity Mfa1-SspB interactions driving biofilm growth. CSE induction of P. gingivalis biofilms of limited pro-inflammatory
potential may explain the increased persistence of this pathogen in smokers. These findings may also be relevant to other
biofilm-induced infectious diseases and conditions.
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Introduction
Periodontitis is an infectious, chronic inflammatory disease of the
supportive structures of the teeth. Smokers often exhibit periodontal
disease that is more severe than in non-smokers, with increased
alveolar bone loss [1], attachment loss [2], tooth mobility, and tooth
loss [3] all apparent and odds ratios of 3 to 7 commonly reported
[4]. Moreover, smokers are more likely to be refractory to treatment
than non-smokers [5]. Indeed, smoking has been reported to be
responsibleformorethan halfofthe 15million periodontitiscasesin
the US, with 42% and 11% attributable to current and former
smoking, respectively [6]. The resultant health burden consumes .
$14 billion per annum [7].
Dental plaque in healthy individuals is predominantly com-
prised of Gram positive commensals, with oral streptococci such as
Streptococcus gordonii estimated to represent up to 70% of the total
bacterial population [8,9,10]. However, in periodontitis there is a
bacterial succession to a microflora rich in Gram negative, obligate
anaerobes that is responsible for the onset and progression of
disease [8,9]. Multiple studies have shown that smokers are more
likely to be infected with the key etiological agent of periodontitis,
P. gingivalis, to harbor higher numbers of P. gingivalis, and to exhibit
more persistent infection by this pathogen [11,12,13,14], relative
to non-smokers.
P. gingivalis persistence in the oral cavity of smokers can be
attributed to a compromised immune response and/or increased
bacterial virulence. We have recently shown, for example, that
P. gingivalis adapts to the environmental stress presented by
cigarette smoke extract (CSE) by altering the expression of
several genes and outer membrane proteins that are key in
lowering its inflammatory potential. Interestingly, specific genes
(PG2133 and PG2134) in the operon coding for the synthesis
and assembly of the major fimbrial antigen of P. gingivalis (fimA)
were induced on exposure to CSE, while several genes in the
capsular biosynthesis locus (capK, PG0117, PG0118 and wecC)
were suppressed [15].
During the development of dental plaque, primary colonizers
first bind to the salivary pellicle on the tooth surface and provide
an attachment stratum that facilitates bacterial succession through
multimodal, receptor-ligand mediated, co-adhesive interactions.
In order for P. gingivalis to establish an oral infection, interactions
with primary or early colonizers, such as S. gordonii, are critical
[16,17]. For example, the long fimbriae (FimA) of P. gingivalis bind
to S. gordonii glyceraldehyde-3 phosphate dehydrogenase (GAPDH)
[17,18] while the shorter fimbriae (Mfa1) bind to streptococcal
surface protein B (SspB) protein [19]. We have previously shown
that an 80 amino acid sequence on SspB is critical for Mfa1
adhesion, with a synthetic peptide of this SspB region, named BAR
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P. gingivalis - S. gordonii biofilms formation [20]. On the other hand,
P. gingivalis capsule production has been shown to be inversely
related to biofilm growth [21].
As CSE-exposure down-regulates capsular genes and upregulates
fimA-related gene activity, but not Mfa1 activity, we hypothesized
that CSE exposure would augment P. gingivalis - S. gordonii biofilms
formation via a FimA-dependent mechanism. We set out to test this
hypothesis in a dual species, open flow biofilm model.
Materials and Methods
Materials
P. gingivalis 33277 and Streptococcus gordonii DL1 were purchased
from the American Type Culture Collection (Manassas, VA).
Escherichia coli TOP10, pBAD gIIIA expression plasmid and
Platinum PCR Supermix High Fidelity were from Invitrogen
(Carlsbad, CA). Gifu Anaerobe Medium [GAM] came from Nissui
Pharmaceutical (Tokyo), while brain heart infusion (BHI) media
and yeast extract were purchased from Beckton Dickinson (Sparks,
MD). HRP-linked anti-Rabbit IgG was from Cell Signaling
Technology (Beverly, MA), while anti-FimA and anti-Mfa1
specific antibodies were custom generated by Cocalico Biologicals
(Reamstown, PA). Alexa Fluor 488 protein labeling kit to tag anti-
P. gingivalis antibodies as well as hexidium iodide were purchased
from Invitrogen. Tetramethylbenzidine, Manostat Carter 4/8
cassette peristaltic pump, 15 mm640 mm cover glass, 0.89 mm
diameter, platinum-cured silicone tubing and Falcon PVC plates
were all purchased from Fisher Scientific (Suwanee, GA). HiTrap
Chelating HP affinity columns came from Amersham Biosciences
Corp. (Piscataway, NJ). FC71 flow cells were obtained from
Biosurface Technologies Corp. (Bozeman, MT). Cloning primers
were bought from Biosynthesis (Lewisville, TX) with initial TA-
cloning performed using pGEM-T Easy from Promega (Madison,
WI) followed by cloning into the pBAD gIIIA expression plasmid
from Invitrogen. BAR peptide was synthesized by Biosynthesis
Inc. (Lewisville, TX). Standard 3R4F reference cigarettes were
obtained from Kentucky Tobacco Research and Development
Center (Lexington, KY). West Pico chemiluminescent substrate
kits and bacterial protein extraction reagent (B-PER) were
purchased from Thermo Scientific (Rockford, IL). a-Bungarotox-
in, BSA and 3,39-Diaminobenzidine (DAB) substrate were
purchased from Sigma Aldrich (St. Louis MO). Nitrocellulose
membranes came from BioRad (Hercules, CA). TNF-a and IL-6
ELISA kits were purchased from eBioscience (San Diego, CA).
Hydroxyapatite discs were purchased from Clarkson Chromatog-
raphy Products (South Williamsport, PA).
Bacterial culture and in vitro modeling of tobacco
exposure
S. gordonii DL-1 was cultured in BHI supplemented with 0.5%
yeast extract under aerobic conditions, without shaking, at 37uC.
P. gingivalis 33277 was grown in GAM or GAM conditioned
with CSE (GAM-CSE) under anaerobic conditions (86% N2,4 %
H2, 10% CO2)a t3 7 uC in a Coy Laboratories (Grass Lake, MI)
anaerobic chamber. Bacteria were harvested at mid- to late-
exponential phase (O.D. of 1 corresponds to 10
9 cells ml
-1). To
prepare CSE, cigarette smoke was drawn through 50 ml GAM by
using a three-way stopcock and a syringe, with 40 ml ‘drags’
performed over a period of 2 sec, one drag every 2 sec. Cigarette
smoke extract (CSE)-conditioned medium was filtered (0.22 mm)
and adjusted to pH 7.2. The nicotine [(S)-3-(1-methyl-2-pyrroli-
dinyl)pyridine] content of GAM-CSE was determined by gas–
liquid chromatography, as previously described [22] and adjusted
to physiologically relevant doses [22,23,24,25]. Unless otherwise
noted, GAM-CSE was employed at a concentration of 4000 ng
nicotine equivalents/ml. We have previously shown that P.
gingivalis is tolerant, with respect to growth and viability, to such
CSE doses [26]. In all experiments, P. gingivalis was either cultured
in GAM or GAM-CSE for two passages. For specific experiments,
CSE-exposed P. gingivalis was reconditioned by culturing back into
GAM for two passages.
Expression and purification of rGAPDH and truncated
SspB
Recombinant GAPDH was produced by PCR amplification of
the coding gene from S. gordonii DL-1 using primers designed using
the previously published sequence for the GAPDH gene in S.
gordonii [27]. To facilitate directional cloning into the expression
vector system, the restriction enzyme sites SacI and XbaI





The PCR product obtained was initially TA-cloned into
pGEM-T Easy and subsequently directionally ligated into the
pBAD gIIIA expression plasmid with a C-terminal 6X-histidine
tag and transformed into expression strain E. coli Top10. rGAPDH
was induced using 2 mM arabinose and purified using HiTrap
chelating HP affinity columns, according to the manufacturer’s
protocol. Purity was confirmed by SDS-PAGE.
Synthesis of BAR and control peptides
BAR peptide (NH2-LEAAPKKVQDLLKKANITVKGAFQLFS-
OH) and a control peptide in which BAR lysine residues were
substituted with the D-enantiomers were synthesized commercially
to $85% purity.
Total FimA and Mfa1 expression by P. gingivalis
P. gingivalis lysates (1610
6 mid-late log cells) were obtained from
cells grown in GAM, GAM-CSE or from reconditioned bacteria.
Due to the large number of genes and proteins dysregulated
by CSE [15,28], it was necessary to normalize western blots to
P. gingivalis cell numbers, as previously described [20,28,29].
Western blots were probed with either rabbit anti-FimA or anti-
Mfa1 IgG and HRP-linked anti-rabbit IgG. Immunoreactive bands
were visualized by chemiluminescence. Imaging and densitometry
were performed using a Kodak 4000 MM image station.
FimA and Mfa1 surface availability
FimA availability to antibody on mid- to late log phase CSE-
exposed and control (GAM) P. gingivalis cells bound to PVC plates
was determined by ELISA. Anti-FimA or anti-P. gingivalis IgG
binding was quantified using an HRP-linked secondary antibody
with tetramethylbenzidine as the chromogenic substrate, essen-
tially as previously described by Pierce et al. [30]. Mfa1 availability
to antibody was assessed identically. The FimA and Mfa1 signal
was normalized to the total P. gingivalis. CSE-induced FimA and
Mfa1 availability to antibody was expressed as percentage of the
control (GAM).
P. gingivalis- S. gordonii dual species biofilms
P. gingivalis and S. gordonii biofilms were formed on saliva coated
cover slips in FC 71 flow cells, as we have previously described
[31,32]. Briefly, S. gordonii cells (25 ml cultures) were suspended in
sterile PBS and labeled with hexidium iodide (1.6 mg/ml;) at room
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0.22 mm filter-sterilized saliva and fixed in the flow cells. Labeled
S. gordonii cells were then introduced into the flow cells using a
Manostat Carter 4/8 cassette peristaltic pump at 6 ml per hour for
approximately 2 hr. The flow cells were then washed with sterile
PBS for 30 min to remove non-adherent S. gordonii cells. P. gingivalis
cells, grown in GAM or GAM-CSE, were harvested by
centrifugation, and re-suspended in PBS before being introduced
into the flow system (flow rate of 6 ml per hour for 1 h). After
washing in PBS, 30 min, bound P. gingivalis was detected using
Alexa-488 labeled rabbit anti-P. gingivalis IgG. P. gingivalis-S. gordonii
biofilms were visualized using an Olympus Fluoview confocal
laser scanning microscope (Olympus, Pittsburgh, PA) under 60x
magnification using the argon laser for visualization of Alexa488
labeling and the HeNe-G laser to visualize hexidium iodide-
labeled streptococci. The number and height of P. gingivalis
microcolonies were determined from 6 randomly chosen frames
using the FluoView software. Microcolony depth was determined
by performing z-plane scans from 0 mmt o5 0mm above the cover
glass surface.
Induction of TNF-a and IL-6 in human innate cells by
P. gingivalis biofilms
P. gingivalis biofilms were grown on pellicle coated hydroxyap-
atite discs (10.6 mm Ø), essentially as described previously [33].
Briefly, hydroxyapatite discs were coated for 24 hours with growth
medium (60% saliva pooled from 3 different donors, 10% FBS) for
24 hrs, 37uC to allow for pellicle formation. After 24 hrs, pellicle-
coated hydroxyapatite discs were immersed in GAM or CSE in 6-
well polystyrene cell culture plates and seeded with 10
9 P. gingivalis
cells grown for two sequential passages in either GAM or CSE to
initiate biofilm formation. Discs were incubated for 48 hr under
anaerobic conditions (86% N2,4 %H 2, 10% CO2)a t3 7 uCi na
Coy Laboratories anaerobic chamber. To determine the inflam-
matory potential of P. gingivalis biofilms, hydroxyapatite discs were
removed from GAM/CSE, washed once in PBS before placing
them in 24-well polystyrene plates containing human PBMCs
(10
6 per well). PBMCs were also simultaneously challenged with
planktonic cultures of P. gingivalis grown in GAM or CSE for two
passages (MOI 10:1).
Adherence of P. gingivalis to rGAPDH
Binding of P. gingivalis cells to immobilized protein was studied
using a protocol adapted from Demuth et al [20]. 1, 5 and 10 mg
of rGAPDH were immobilized on nitrocellulose membranes using
a vacuum dot blot apparatus. Membranes were then blocked with
3% BSA for an hour followed by overnight incubation with
P. gingivalis at 10
9 cfu/mL from GAM/CSE cultures at RT. Bound
P. gingivalis was then quantified using rabbit anti- P. gingivalis IgG
followed by HRP-tagged anti-rabbit secondary antibody and DAB
substrate. Mean dot intensity from three independent blots was
calculated using ImageJ software (NIH) and background signals
(no immobilized protein) subtracted.
P. gingivalis aggregation assays
Fimbriae directly increase P. gingivalis adhesiveness by promot-
ing inter-bacterial aggregation [34] [35] As CSE increases fimbrial
density, we determined whether CSE promotes bacterial auto-
aggregation. P. gingivalis, grown in GAM or CSE, was harvested
by centrifugation and suspended in sterile PBS at O.D. ,1.
Aggregation of P. gingivalis was assessed spectrophotometerically
(Abs600 nm) over 8 hrs using an Eppendorf Biophotometer Plus
spectrophotometer.
Influence of exogenous S. gordonii ligands (GAPDH and
BAR) on dual species CSE-induced biofilms
CSE and control (GAM) P. gingivalis-S. gordonii biofilms were
formed and analyzed, as described above with a slight modifica-
tion. P. gingivalis grown in GAM or GAM-CSE was pre-treated
with 3.4 mM GAPDH or BAR peptide for 30 minutes before
introduction into the flow chamber. The number and height of
P. gingivalis microcolonies were determined as described in the dual
species biofilm section.
Statistical Analysis
Data were evaluated by two-tailed t tests and analysis of
variance (ANOVA), as appropriate, using the InStat program
(Graphpad Software, La Jolla, CA). Statistical significance was set
at p,0.05.
Figure 1. CSE exposure does not influence total protein levels
or surface availability of Mfa1. (A) Western blots of 1 x 10
6 P.
gingivalis cell lysates sequentially passaged in GAM, GAM-CSE, and then
fresh GAM, respectively and re-probed with rabbit anti-Mfa1 antibody
(blot was first probed for FimA, as shown in Supplemental Figure 1).
(B) Relative band intensities for Mfa1 expression (B) indicate Mfa1
protein levels remain unaltered by CSE exposure. Surface availability
ELISAs for Mfa1 (C) confirm that Mfa1 availability on the P. gingivalis
surface remains unchanged. *p , 0.05.
doi:10.1371/journal.pone.0027386.g001
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CSE exposure upregulates surface expression of
surface-available FimA but not Mfa1
Our previous studies suggested that exposure to CSE augments
the expression of the major fimbrial antigen of P. gingivalis (FimA)
at the transcriptional (microarray and RT-PCR) and protein
levels, while simultaneously down-regulating capsular polysaccha-
rides [15,28]. CSE-induced upregulation of FimA is confirmed in
Figure S1. However, CSE exposure has no effect on the absolute
protein level of the minor fimbrial antigen of P. gingivalis (Mfa1;
Figure 1A and B) or on Mfa1 surface presentation, as assessed by
availability to anti-Mfa1 antibodies (Figure 1C).
CSE exposure increases P. gingivalis-S. gordonii biofilm
formation
Figures 2A and 2B show representative z-stack images of
microcolonies formed by P. gingivalis grown in GAM and GAM-
CSE, respectively, on S. gordonii. As presented in Figure 2C and
2D, CSE exposure resulted in an approximately 2-fold increase in
the total number of P. gingivalis-S. gordonii microcolonies formed as
well as an approximately 3-fold increase in microcolony height,
relative to control biofilms (p,0.05 and p,0.01, respectively).
CSE exposure decreases the inflammatory activity of
P. gingivalis biofilms
The pro-inflammatory activity of CSE-exposed P. gingivalis
(Black bars) grown either in planktonic form or in monospecies
biofilms was lower than that of unexposed bacteria (white bars), as
determined by IL-6 and TNF-a release from primary human
PBMCs, and- shown in Figure 3A and B respectively.
Furthermore, this reduced immune potential was not influenced
by a ´-bungarotoxin, an a ´7 nAChR and cholinergic anti-inflamma-
tory pathway antagonist [36], (see Figure 3). Therefore, it is
unlikely that repressed cytokine production can be attributed to
nicotine carry over from growth medium or bacterial sequestration
and, rather, is a direct consequence of CSE-induced alteration to
P. gingivalis itself.
CSE exposure does not induce P. gingivalis
auto-aggregation
Aggregation of planktonic P. gingivalis did not occur in P.
gingivalis grown in CSE or in GAM-CSE (see Figure S2). Rather,
the slow settling that is typical of this bacterium was apparent,
suggesting that auto-aggregation does not contribute to CSE-
induced P. gingivalis-S. gordonii biofilm formation.
CSE exposure increases P. gingivalis binding to
immobilized FimA ligand (rGAPDH)
To determine whether CSE-induced FimA upregulation played
a functional role in P. gingivalis - S. gordonii associations, adherence
of P. gingivalis to immobilized rGAPDH was assessed. As shown in
Figure 4, CSE-exposed P. gingivalis exhibited increased binding to
rGAPDH (p,0.01 and p,0.001), compared to control bacteria
(GAM), and did so in a dose-dependent manner.
CSE-induced P. gingivalis-S. gordonii biofilm formation is
FimA-enhanced but Mfa1-dependent
The efficacy of rGAPDH protein to interfere with CSE-
induced P. gingivalis-S. gordonii biofilms formation was subsequent-
ly assessed. CSE-exposed P. gingivalis associated strongly with
S. gordonii, compared to controls (Figures 5A and B). While
Figure 2. CSE exposure augments P. gingivalis - S. gordonii biofilm formation. Total number and height of microcolonies (yellow) formed by
Hexidium iodide labeled S. gordonii (red) and Alexa-488 labeled P. gingivalis (green) biofilms, formed in an open flow system were quantified by
taking optical section along the x-y and z axis at 1 mm intervals with a confocal microscope. CSE-exposed P. gingivalis associated strongly with S.
gordonii as reflected by increased number of microcolonies formed (B) compared to control P. gingivalis grown in GAM (A). Total numbers (C) and
average microcolony height (D) were quantified from 6 randomly chosen microscopic fields per biofilm using the FluoView software. *p,0.05;
**p,0.01.
doi:10.1371/journal.pone.0027386.g002
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influence on microcolony numbers, rGAPDH did decrease
microcolony height by 65% relative to control biofilms (p,0.05
and p,0.01); (Figures 5C and D). We have previously shown
that a synthetic BAR peptide, characterized by Daep et al,
efficiently blocks the binding of Mfa1 to SspB [32,37]. Therefore,
we used pre-incubation with BAR to ascertain the importance of
Mfa1 in CSE-induced P. gingivalis-S. gordonii biofilm formation. As
shown in Figure 5E and 5F,B A Rp e p t i d ea t3 . 4mM completely
abrogated (100%) dual species biofilm formation under CSE-
exposed and control conditions.
Discussion
Our prior work has established that CSE-exposure increases
P. gingivalis monospecies biofilm formation. However, in vivo it is
P. gingivalis-early colonizer (particularly streptococcal) interactions
that are considered critical for P. gingivalis to establish itself and
maintain a presence in dental plaque. Furthermore, microbes may
interact with the immune response in different manners in biofilms
than in planktonic form. Thus we have extended our prior studies
to observe the influence of CSE on P. gingivalis – S. gordonii;
mechanisms that promote CSE-induced P. gingivalis – S. gordonii
interaction; and the pro-inflammatory potential of CSE-exposed
biofilms.
We have previously reported, using microarrays representative
of the P. gingivalis genome that CSE exposure resulted in the
differential regulation of 6.8% of P. gingivalis genes in planktonic
culture. Of particular relevance to biofilm formation were two
major fimbriae synthesis genes that were induced by CSE
(PG2133 and PG2134) as well as several genes in the capsular
operon (capK [PG0111], PG0117, PG0118 and wecC [PG0108])
Figure 3. CSE exposure reduces inflammatory activity of P. gingivalis biofilms. Human PBMCs (1610
6) were challenged with P. gingivalis
grown in GAM or CSE as planktonic cultures (MOI 10:1) or with 48 hr P. gingivalis biofilms formed on HA discs in GAM or CSE and with 1 mg/ml E. coli
LPS as positive control. Additionally, PBMCs were pre-treated with a–bungarotoxin (500 ng/ml for 30 min) before addition of biofilm discs. Cells were
stimulated overnight and cell-free supernatants were analyzed for IL-6 (A) and TNF-a (B) levels by ELISA. *p,0.05; **p,0.01; ***p,0.001.
doi:10.1371/journal.pone.0027386.g003
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and fimbrial genes was reflected at the ultrastructural level, as
confirmed by electron microcopy, and at the functional level, as
shown by altered host-pathogen interactions [15,28].
We now show that CSE-exposure results in increased surface
availability of FimA protein, but not Mfa1, and increases P.
gingivalis biofilm formation in a dual species model. Thus, CSE-
induced fimbrial gene dysregulation is functionally significant.
FimA is known to play multiple roles in P. gingivalis virulence, but is
best characterized as a fimbrial adhesin that is important in
binding of P. gingivalis to the salivary pellicle [38].
Mfa1 is essential for P. gingivalis-S. gordonii biofilm formation, as
illustrated bySspB-deficient mutantsand competitive inhibition with
BAR peptide [19,31,32,39]. We show herein that, nevertheless,
FimA binds strongly to immobilized rGADPH; CSE-induced FimA
surface upregulation significantly enhances dual species biofilm;
and that the addition of an exogenous FimA ligand suppresses
P. gingivalis - S. gordonii biofilms. FimA-GAPDH interactions are of
much lower affinity than Mfa1-SSpB/BAR interactions, with IC50
values for inhibition of dual species biofilms reported to be in
the region of 300-400 mg/ml and 4 mg/ml for GAPDH and
SspB peptides respectively [31,32,40]. Thus, it would seem that a
Figure 4. CSE exposure promotes adherence of intact P.
gingivalis to rGAPDH. P. gingivalis adherence to immobilized rGAPDH
was assessed by dot blot. 10
9 cfu/ml of P. gingivalis, grown either in
GAM or CSE, were added to each blot and adherent bacteria detected
using anti-P. gingivalis IgG. Averaged mean intensities from three
independent blots indicate CSE exposure augments binding to GAPDH
in a dose-dependent manner. **p,0.01; ***p,0.001.
doi:10.1371/journal.pone.0027386.g004
Figure 5. CSE augmentation of biofilm formation is FimA-enhanced and Mfa1-dependent. As shown previously CSE exposure
significantly increased P. gingivalis association with S. gordonii (B) compared to control P. gingivalis grown in GAM (A) as reflected by total numbers of
microcolonies (yellow) formed. Pre-treatment of P. gingivalis with rGAPDH (3.4 mM) reduced association (microcolony height and numbers) between
CSE-exposed P. gingivalis and S. gordonii (D) but had no effect on control P. gingivalis grown in GAM (C). Pretreatment with BAR peptide (3.4 mM)
completely abolished any association between S. gordonii and P. gingivalis grown either in GAM (E) or CSE (F). Total number and height of
microcolonies (yellow) formed by Hexidium iodide labeled S. gordonii (red) and Alexa488 labeled P. gingivalis (green) biofilms formed in an open flow
system were quantified by taking optical section along the x-y and z axis at 1 mm intervals under a confocal microscope and presented in figures (G)
and (H) respectively. *p,0.05; **p,0.01; ***p,0.001.
doi:10.1371/journal.pone.0027386.g005
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gordonii adhesive contacts. Subsequently, high affinity Mfa-SspB
interactions are critical in stabilizing the biofilm and possibly
promoting P. gingivalis persistence in the host.
While auto-aggregation in planktonic culture may not be
directly related to biofilm formation in vivo, the lack of CSE-
induced P. gingivalis auto-auggregation noted in vitro suggests that
bacterial clumping did not contribute to increased biofilm
formation in the flow cell system.
These data suggest that, in smokers and non-smokers alike, anti-
biofilm strategies that target both FimA and Mfa1 may be more
successful in inhibiting P. gingivalis colonization than the use of
anti-Mfa1 agents alone. They also suggest that the considerable
efforts currently underway to develop FimA-focused vaccination
strategies [41,42] may be particularly relevant to tobacco users,
the section of society who are most likely to harbor P. gingivalis and
who share the largest periodontal disease burden. This hypothesis
is supported by the discovery of a FimA binding domain (amino
acid residues 166 to 183) on the GADPH protein produced
by another oral streptococcus species, S. oralis, along with the
realization that this peptide may represent another potent
inhibitor of P. gingivalis colonization in the oral cavity [40].
It should also be remembered that enhancement of FimA
surface expression may have other pathological consequences that
are unrelated to streptococcal adhesion. Recently, for example, it
has been shown that FimA binds several plasma factors,
particularly prekallikrein, and may thus be involved in subversion
of the kinin generating system to the benefit of P. gingivalis and
disadvantage of the host [43]. FimA also appears to play important
roles in the invasion and activation of host cells such as osteoblasts
[44] and vascular endothelial cells [45] by P. gingivalis. Indeed, the
invasion and activation of host cells is expected to be a critical step
in many of the fatal and debilitating chronic systemic diseases
associated with periodontal infections. Enhanced FimA expression
may also promote P. gingivalis adherence to other periodontal
pathogens like Treponema denticola [46] promoting establishment of
a complex pathogenic plaque.
It is of interest that initial characterization of the host response
to CSE-enhanced P. gingivalis mono-species biofilms suggests that
they exhibit considerably reduced inflammatory potential than
control biofilms, as assessed by stimulation of TNF-a ´ and IL-6
from primary human innate cells. P. gingivalis does not express
nicotinic receptors, does not internalize nicotine [47,48] and
bacteria were washed prior to stimulating PBMCs with biofilms.
Nevertheless, we thought it prudent to ensure that inflamma-
tory suppression subsequent to engagement of the a ´7 nicotinic
acetylcholine receptor by nicotine [36] did not occur. The reduced
cytokine profile observed with CSE-exposed biofilms was not
influenced by pre-incubation with the nAChR antagonist,
a ´-bungarotoxin. Therefore, the possibility of nAChR-initiated
activation of the cholinergic anti-inflammatory pathway by
nicotine carry over is unlikely. These results are in keeping with
our prior in vitro studies that have shown that intact P. gingivalis
exposed to CSE elicit a reduced ability to induce cytokines under
the transcriptional control of the NF-e ˆB system [15,28]. While
CSE promotes FimA expression, FimA itself is an inefficient
TLR2-agonist and induces immune hyporesponsiveness in innate
cells in a TLR2-IRAK-1-IkBa-dependent manner [28]. More
recent data suggest that the TLR-engagement domain of FimA lies
in the signal peptide with a cysteine residue at single amino acid
position 19A essential [49]. Our findings are also consistent with
established in vivo conditions. Patients who smoke exhibit increased
susceptibility to periodontitis and are more likely to display severe
disease and be refractory to treatment [5]. Paradoxically, smokers
demonstrate reduced clinical inflammation, that is, diminished
edema, bleeding on probing, and local cytokine production
compared to non-smokers [5,50]. Thus, a reduced inflammatory
capacity of CSE-exposed P. gingivalis biofilms is in keeping with the
established clinical apparition of periodontitis in tobacco smokers.
In summary, the majority of periodontitis cases in the US
have been directly attributed to tobacco smoking [6], yet the
mechanisms underlying this smoking-induced and exacerbated
infectious disease are poorly understood. CSE exposure results in
increased dual species biofilm formation in a manner that is FimA-
enhanced, Mfa1-dependent, and does not involve CSE-induced
P. gingivalis aggregation. The dramatic CSE-induced promotion of
biofilm formation is likely to contribute to the established clinical
phenomenon of increased P. gingivalis infection and perseverance
in the oral cavity of smokers. These findings are also relevant to
ongoing efforts to develop effective anti-FimA vaccination
strategies for the treatment of periodontal diseases and may have
implications for other biofilm-associated diseases.
Supporting Information
Figure S1 CSE exposure increases total protein levels
and surface availability of FimA. (A) Western blots of 1610
6
P. gingivalis cell lysates sequentially passaged in GAM, GAM-CSE,
and then fresh GAM, respectively and probed with rabbit anti-
FimA antibody (A). (B) Relative band intensities for FimA
expression indicate FimA is reversibly and significantly upregu-
lated on CSE-exposure. Surface availability ELISA for FimA
confirms that upregulated FimA is available on the P. gingivalis
surface. *p,0.05; **p,0.01; ***p,0.001.
(TIF)
Figure S2 CSE does not induce P. gingivalis auto-
aggregation. Aggregation of P. gingivalis (10
9 cells/ml) grown
in either in GAM (grey line) or CSE (black line) and suspended in
PBS was monitored by measuring optical density (O.D.600) of over
time. CSE does not increase P. gingivalis aggregation.
(TIFF)
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